Publications by authors named "Briel Matthias"

Claim this Profile
I
Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study.
Elias R Zehnder, Christof Manuel Schönenberger, Julia Hüllstrung, Mona Elalfy, Beverley Nickolls, Matthias Cavassini, Matthias Briel

J Clin Epidemiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine for the secondary prevention of cardiovascular events.
Fahim Ebrahimi, Ramin Ebrahimi, Maximilian Beer, Christof Manuel Schönenberger, Hannah Ewald, Matthias Briel

Cochrane Database Syst Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study' [Journal of Clinical Epidemiology, 188 (2025) 111973].
Elias R Zehnder, Christof Manuel Schönenberger, Julia Hüllstrung, Mona Elalfy, Beverley Nickolls, Matthias Cavassini, Matthias Briel

J Clin Epidemiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting guidelines can be used to foster reporting of evidence-based research principles: a cross-sectional study.
Tea Kabić, Marija Šimundić Munitić, Ishanka Weerasekara, Malgorzata M Bala, Joanna Zajac, Matthias Briel

J Clin Epidemiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial.
Johannes M Schwenke, Andreas M Schmitt, Stuart McLennan, Perrine Janiaud, Heinz Läubli, Matthias S Matter, Matthias Briel

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias.
Ala Taji Heravi, Dmitry Gryaznov, Jason W Busse, Christof Manuel Schönenberger, Belinda von Niederhäusern, Matthias Briel

J Clin Epidemiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public availability of randomized clinical trial protocols: a repeated meta-research study.
Christof Manuel Schönenberger, Malena Chiaborelli, Ala Taji Heravi, Lukas Kübler, Pooja Gandhi, Matthias Briel

J Clin Epidemiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonregistration, Discontinuation, and Nonpublication of Randomized Trials: A Systematic Review.
Benjamin Speich, Ala Taji Heravi, Christof M Schönenberger, Lena Hausheer, Dmitry Gryaznov, Matthias Briel

JAMA Netw Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI).
Declan Devane, Matthias Briel, Sanjay Bhagani, Nadine Boesten, Stephanie Buchholz

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and results.
Shaun Treweek, Shoba Dawson, Kamlesh Khunti, Murat Akand, Matthias Briel

Trials· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, design, and statistical methods in platform trials: a systematic review.
Clément R Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, Matthias Briel

J Clin Epidemiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Forge Guidance 5: ethical considerations in randomised Studies Within A Trial (SWATs).
Hanne Bruhn, Shaun Treweek, Charles Weijer, Matthias Briel, Mike Clarke

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do peer reviewers comment on reporting items as instructed by the journal? A secondary analysis of two randomized trials.
Hillary Wnfried Ramirez, Malena Chiaborelli, Christof M Schönenberger, Katie Mellor, Alexandra N Griessbach, Matthias Briel

J Clin Epidemiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials.
Chengliang Yang, Linda Lapp, Alain Amstutz, Matthias Briel, Casey P Shannon

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: the open, prospective Community-Based chronic Care Lesotho (ComBaCaL) cohort - design, baseline chronic disease risk factors and hypertension and diabetes care cascades.
Felix Gerber, Giuliana Sanchez-Samaniego, Thesar Tahirsylaj, Thabo Ishmael Lejone, Tristan Lee, Matthias Briel

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials.
Alain Amstutz, Stefan Schandelmaier, Hannah Ewald, Benjamin Speich, Johannes M Schwenke, Matthias Briel

Lancet Respir Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function.
Annette Audigé, Alain Amstutz, Macé M Schuurmans, Patrizia Amico, Dominique L Braun, Matthias Briel

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial budgeting approaches in Switzerland-a meta-research study.
Alexandra Griessbach, Malena Chiaborelli, Klaus Ehrlich, Regina Grossmann, María De Medina Redondo, Matthias Briel

Trials· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.
Jim M Smit, Philip A Van Der Zee, Sara C M Stoof, Michel E Van Genderen, Dominic Snijders, Matthias Briel

Lancet Respir Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials.
Ying Wang, Sheri Keitz, Matthias Briel, Paul Glasziou, Romina Brignardello-Petersen

BMJ· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource use and costs of investigator-sponsored randomized clinical trials in Switzerland, Germany, and the United Kingdom: a metaresearch study.
Alexandra Griessbach, Benjamin Speich, Alain Amstutz, Lena Hausheer, Manuela Covino, Matthias Schwenkglenks, Matthias Briel

J Clin Epidemiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study.
Alain Amstutz, Frédérique Chammartin, Annette Audigé, Anna L Eichenberger, Dominique L Braun, Matthias Briel

J Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review.
Alain Amstutz, Christof M Schönenberger, Benjamin Speich, Alexandra Griessbach, Johannes M Schwenke, Matthias Briel

J Clin Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the UK, and Germany.
Alexandra Griessbach, Benjamin Speich, Gilles Dutilh, Shaun Treweek, Matthias Schwenkglenks, Matthias Briel

Trials· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-based management of arterial hypertension and cardiovascular risk factors by lay village health workers for people with controlled and uncontrolled blood pressure in rural Lesotho: joint protocol for two cluster-randomized trials within the ComBaCaL cohort study (ComBaCaL aHT Twic 1 and ComBaCaL aHT TwiC 2).
Felix Gerber, Ravi Gupta, Thabo Ishmael Lejone, Thesar Tahirsylaj, Tristan Lee, Matthias Briel

Trials· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis